SPORE in Cervical Cancer - Project 5: A Phase I Safety and Immunogenicity Study of a HP16- Specific Therapeutic Protein, TA-CIN, Administered Intratumorally During Chemoradiation, in Patients with Inoperable HPV16+ Cervical Cancer

Rebecca Landy

When Can Cervical Screening Safely be Ceased?

Cervix uteri

Bianca De Stavola

Newton001-Developing tools to study inequalities in women's access to breast and cervical cancer control activities in Brazil using health-related DB

Cervix uteri Breast

Karl Munger

Biological Activity of HPV E7 in Human Epithelial Cells

Cervix uteri

Pathology

Louise Kuhn

Improving specificity of HPV Screen-and-Treat in South Africa

Cervix uteri

Kathleen Schmeler

NCI Pilot Collaborations with LMICs in Global Cancer Research at NCI-Designated Cancer Centers (P30 Supplement)

Cervix uteri

Matthias Egger

International Epidemiologic Databases to Evaluate AIDS-Southern Africa (IeDEA-SA)

Cervix uteri

Global Noncommunicable Diseases Intiatives

Primary and secondary prevention of cervical cancer in Tanzania

Cervix uteri

Robert Hoover

Norwegian Studies of the Association of Pregnancy and Perinatal Characteristics with Cancer Risk in Mothers and Offspring

Testis Prostate Ovary Corpus uteri Cervix uteri Breast

Aaron A Tobian

Oncogenic HPV, Mucosal Immune Response and Risk of HIV Acquisition

Cervix uteri

Pathology